|
|||||
|
|
Phase II study of erlotinib as third-line monotherapy in patients with advanced non-small-cell lung cancer without epidermal growth factor receptor mutations |
|
| Authors: | Matsuura Shun Inui Naoki Ozawa Yuichi Nakamura Yutaro Toyoshima Mikio Yasuda Kazumasa Yamada Takashi Shirai Toshihiro Suganuma Hideki Yokomura Koji Suda Takafumi Chida Kingo |
| Affiliation: | Hamamatsu University School of Medicine, 1-20-1 Handayama, Hamamatsu 431-3192, Japan. inui@hama-med.ac.jp |
| Abstract: | |
| Keywords: | |
| 本文献已被 PubMed 等数据库收录！ | |